DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
CH5132799
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CH5132799
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CARBENDAZIM
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma; Neoplasms
Unknown
CARBENDAZIM
×
Maximum Phase:
1
First Approval:
None
UNII:
H75J14AA89
Molecule Type:
Small molecule
Molecular Formula:
C9H9N3O2
Molecular Weight:
191.19
AlogP:
1.74
PSA:
67.01
HBD:
2.0
HBA:
#RotB:
1.0
Source:
TRICHOSTATIN
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
TRICHOSTATIN
×
Maximum Phase:
1
First Approval:
None
UNII:
3X2S926L3Z
Molecule Type:
Small molecule
Molecular Formula:
C17H22N2O3
Molecular Weight:
302.37
AlogP:
2.58
PSA:
69.64
HBD:
2.0
HBA:
#RotB:
6.0
Source:
VT-1598
1
Small molecule
Investigational
Unknown
Unknown
Coccidioidomycosis
Unknown
VT-1598
×
Maximum Phase:
1
First Approval:
None
UNII:
AV9K9X720D
Molecule Type:
Small molecule
Molecular Formula:
C31H20F4N6O2
Molecular Weight:
584.53
AlogP:
4.88
PSA:
109.74
HBD:
1.0
HBA:
#RotB:
8.0
Source:
ZIDEBACTAM
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ZIDEBACTAM
×
Maximum Phase:
1
First Approval:
None
UNII:
YPM97423DB
Molecule Type:
Small molecule
Molecular Formula:
C13H21N5O7S
Molecular Weight:
391.41
AlogP:
-1.86
PSA:
157.38
HBD:
4.0
HBA:
#RotB:
4.0
Source:
TUROFEXORATE ISOPROPYL
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Bile acid receptor FXR agonist
TUROFEXORATE ISOPROPYL
×
Maximum Phase:
1
First Approval:
None
UNII:
S6KDM312I5
Molecule Type:
Small molecule
Molecular Formula:
C25H24F2N2O3
Molecular Weight:
438.47
AlogP:
5.17
PSA:
62.4
HBD:
1.0
HBA:
#RotB:
3.0
Source:
MK-7246
1
Small molecule
Investigational
Unknown
Unknown
Unknown
G protein-coupled receptor 44 antagonist
MK-7246
×
Maximum Phase:
1
First Approval:
None
UNII:
X0LHZ71TLK
Molecule Type:
Small molecule
Molecular Formula:
C21H21FN2O4S
Molecular Weight:
416.47
AlogP:
3.04
PSA:
79.61
HBD:
1.0
HBA:
#RotB:
5.0
Source:
ETACONAZOLE
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Prostatic Neoplasms
Unknown
ETACONAZOLE
×
Maximum Phase:
1
First Approval:
None
UNII:
3MT15AE9VG
Molecule Type:
Small molecule
Molecular Formula:
C14H15Cl2N3O2
Molecular Weight:
328.2
AlogP:
3.26
PSA:
49.17
HBD:
0.0
HBA:
#RotB:
4.0
Source:
SIMMITECAN
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
SIMMITECAN
×
Maximum Phase:
1
First Approval:
None
UNII:
T4H02O147G
Molecule Type:
Small molecule
Molecular Formula:
C34H38N4O6
Molecular Weight:
598.7
AlogP:
4.26
PSA:
114.2
HBD:
1.0
HBA:
#RotB:
5.0
Source:
DIINDOLYLMETHANE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
DIINDOLYLMETHANE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RO-4987655
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Dual specificity mitogen-activated protein kinase kinase 1 inhibitor
RO-4987655
×
Maximum Phase:
1
First Approval:
None
UNII:
I3733P75ML
Molecule Type:
Small molecule
Molecular Formula:
C20H19F3IN3O5
Molecular Weight:
565.29
AlogP:
3.16
PSA:
100.13
HBD:
3.0
HBA:
#RotB:
8.0
Source:
PLUMBAGIN
1
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms, Castration-Resistant
Unknown
PLUMBAGIN
×
Maximum Phase:
1
First Approval:
None
UNII:
YAS4TBQ4OQ
Molecule Type:
Small molecule
Molecular Formula:
C11H8O3
Molecular Weight:
188.18
AlogP:
1.72
PSA:
54.37
HBD:
1.0
HBA:
#RotB:
0.0
Source:
CEP-2563
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Neurotrophic tyrosine kinase receptor inhibitor
CEP-2563
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NT-219
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
NT-219
×
Maximum Phase:
1
First Approval:
None
UNII:
K1WT1A1UP5
Molecule Type:
Small molecule
Molecular Formula:
C16H14BrNO5S
Molecular Weight:
412.26
AlogP:
3.11
PSA:
113.18
HBD:
6.0
HBA:
#RotB:
4.0
Source:
RELACATIB
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
RELACATIB
×
Maximum Phase:
1
First Approval:
None
UNII:
BL51M8CB8R
Molecule Type:
Small molecule
Molecular Formula:
C27H32N4O6S
Molecular Weight:
540.64
AlogP:
2.9
PSA:
138.68
HBD:
2.0
HBA:
#RotB:
8.0
Source:
TEDALINAB
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Cannabinoid CB2 receptor agonist
TEDALINAB
×
Maximum Phase:
1
First Approval:
None
UNII:
5R7X34Y6Q1
Molecule Type:
Small molecule
Molecular Formula:
C19H21F2N3O
Molecular Weight:
345.39
AlogP:
4.04
PSA:
46.92
HBD:
1.0
HBA:
#RotB:
2.0
Source:
CARD-024
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CARD-024
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MSC-2364447
1
Small molecule
Investigational
Unknown
Unknown
Lupus Erythematosus, Systemic
Tyrosine-protein kinase BTK inhibitor
MSC-2364447
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LIOTHYRONINE I 131
1
Small molecule
Investigational
Unknown
Unknown
Heart Defects, Congenital
Unknown
LIOTHYRONINE I 131
×
Maximum Phase:
1
First Approval:
None
UNII:
86AZ0G22V2
Molecule Type:
Small molecule
Molecular Formula:
C15H12I3NO4
Molecular Weight:
662.98
AlogP:
3.95
PSA:
92.78
HBD:
3.0
HBA:
#RotB:
5.0
Source:
NIKKOMYCIN
1
Small molecule
Investigational
Unknown
Unknown
Coccidioidomycosis
Unknown
NIKKOMYCIN
×
Maximum Phase:
1
First Approval:
None
UNII:
9Z22C3QQCJ
Molecule Type:
Small molecule
Molecular Formula:
C20H25N5O10
Molecular Weight:
495.45
AlogP:
-3.48
PSA:
250.32
HBD:
8.0
HBA:
#RotB:
8.0
Source:
KPT-8602
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
KPT-8602
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CROCETIN
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CROCETIN
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GANTACURIUM
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GANTACURIUM
×
Maximum Phase:
1
First Approval:
None
UNII:
N9VK9ZO25E
Molecule Type:
Small molecule
Molecular Formula:
C53H69ClN2O14+2
Molecular Weight:
993.59
AlogP:
7.84
PSA:
144.9
HBD:
0.0
HBA:
#RotB:
23.0
Source:
XL-888
1
Small molecule
Investigational
Unknown
Unknown
Melanoma; Neoplasms; Skin Neoplasms
Unknown
XL-888
×
Maximum Phase:
1
First Approval:
None
UNII:
7M346920EV
Molecule Type:
Small molecule
Molecular Formula:
C29H37N5O3
Molecular Weight:
503.65
AlogP:
4.22
PSA:
117.42
HBD:
3.0
HBA:
#RotB:
9.0
Source:
MK-2201
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Serine/threonine-protein kinase AKT inhibitor
MK-2201
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RG-7167
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Dual specificity mitogen-activated protein kinase kinase; MEK1/2 inhibitor
RG-7167
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TTP-607
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma; Neoplasms
Serine/threonine-protein kinase Aurora inhibitor
TTP-607
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
XANTHOHUMOL
1
Small molecule
Investigational
Unknown
Unknown
Crohn Disease
Unknown
XANTHOHUMOL
×
Maximum Phase:
1
First Approval:
None
UNII:
T4467YT1NT
Molecule Type:
Small molecule
Molecular Formula:
C21H22O5
Molecular Weight:
354.4
AlogP:
4.22
PSA:
86.99
HBD:
3.0
HBA:
#RotB:
6.0
Source:
GMI-1271
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GMI-1271
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TAK-593
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Platelet-derived growth factor receptor inhibitor
TAK-593
×
Maximum Phase:
1
First Approval:
None
UNII:
H3I42X8XX7
Molecule Type:
Small molecule
Molecular Formula:
C23H23N7O3
Molecular Weight:
445.48
AlogP:
3.47
PSA:
115.44
HBD:
2.0
HBA:
#RotB:
6.0
Source:
GSK-356278
1
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder; Huntington Disease
Unknown
GSK-356278
×
Maximum Phase:
1
First Approval:
None
UNII:
1QTA9P992C
Molecule Type:
Small molecule
Molecular Formula:
C21H25N7O2S
Molecular Weight:
439.55
AlogP:
3.76
PSA:
103.78
HBD:
1.0
HBA:
#RotB:
6.0
Source:
PWT-33579
1
Small molecule
Investigational
Unknown
Unknown
Unknown
PI3-kinase p110-alpha subunit inhibitor
PWT-33579
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MIP-1095 I-123
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MIP-1095 I-123
×
Maximum Phase:
1
First Approval:
None
UNII:
HD4940602J
Molecule Type:
Small molecule
Molecular Formula:
C19H25IN4O8
Molecular Weight:
560.33
AlogP:
1.65
PSA:
194.16
HBD:
7.0
HBA:
#RotB:
13.0
Source:
TAK-243
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
TAK-243
×
Maximum Phase:
1
First Approval:
None
UNII:
V9GGV0YCDI
Molecule Type:
Small molecule
Molecular Formula:
C19H20F3N5O5S2
Molecular Weight:
519.53
AlogP:
1.75
PSA:
152.07
HBD:
4.0
HBA:
#RotB:
7.0
Source:
AXT914
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
AXT914
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
82
83
84
85
86
87
88
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA